FDA Adverse Event Injury Summary report: N

ESPRIT¿

MDR report key: 24756905 · Received April 1, 2026

Report

Report Number
2024168-2026-01342
Event Type
Injury
Date Received
April 1, 2026
Date of Event
February 27, 2026
Report Date
April 1, 2026
Manufacturer
ABBOTT VASCULAR INC.
Product Code
NXW
UDI-DI
08717648357473
PMA / PMN Number
P230036
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SZ
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE WAS NOT RETURNED FOR ANALYSIS. PRODUCTION RECORD AND CORRECTIVE AND PREVENTATIVE ACTIONS (CAPA) REVIEWS WERE PERFORMED AND REVEALED NO INDICATION OF A PRODUCT QUALITY ISSUE. ADDITIONALLY, A QUERY OF THE COMPLAINT HANDLING DATABASE FOR THE REPORTED LOT REVEALED THERE IS NO INDICATION OF A LOT SPECIFIC ISSUE. THE REPORTED PATIENT EFFECT OF OCCLUSION IS LISTED IN THE ESPRIT BTK EVEROLIMUS ELUTING RESORBABLE SCAFFOLD SYSTEM INSTRUCTIONS FOR USE AS A KNOWN PATIENT EFFECT OF CORONARY SCAFFOLDING PROCEDURES. A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT, AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED. THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING. B3: DATE OF EVENT ESTIMATED. THE ADDITIONAL DEVICE MENTIONED IN B5 WILL BE FILED UNDER A SEPARATE MEDWATCH REPORT.

Description of Event or Problem · 0

IT WAS REPORTED THE INITIAL PROCEDURE WAS PERFORMED ON (B)(6) 2025 WHERE TWO 3.50X28 ESPRIT BTK SCAFFOLDS WERE IMPLANTED OVERLAPPING IN THE ANTERIOR TIBIAL ARTERY WITHOUT ISSUE. PATIENT HAD GOOD INFLOW AFTER IMPLANTATION WITH GOOD OUTFLOW TO THE FOOT. AT THE THREE MONTH FOLLOW UP IT WAS NOTED BOTH OF THE SCAFFOLDS HAD OCCLUDED. NO TREATMENT WAS PERFORMED AS THE WOUND WAS ALREADY HEALING. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
472268 ESPRIT¿ STENT, INFRAPOPLITEAL, ABSORBABLE NXW ABBOTT VASCULAR INC. ESPRIT BTK 5080661 08717648357473

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other